Novavax (NVAX) Gross Margin (2011 - 2026)
Novavax (NVAX) recorded Gross Margin of 74.87% in Q2 2026, down 18.72 percentage points from 93.59% a year earlier and down 3.12 percentage points from the prior quarter.
Powered by 
Analysis
Novavax (NVAX) Gross Margin (2011 - 2026) Analysis & Trends
On a TTM basis, Novavax's Gross Margin came in at 78.60% as of Jun 30, 2026, down 9.65 percentage points year-over-year; for FY2025, it was 93.50%, up 23.22 percentage points from FY2024.
- Annual Gross Margin has increased for three straight years, though with a five-year change of -6.50 percentage points (FY2020 to FY2025).
- Across earlier years, Gross Margin came in at 70.28% in FY2024 (+5.23 pp), 65.05% in FY2023 (+10.60 pp), 54.46% in FY2022 (-45.54 pp) and 100.00% in FY2021 (unchanged).
- Quarterly Gross Margin has ranged from -45.80% in Q2 2022 to 100.00% in Q4 2021 over the past five years.
- On a year-over-year basis, Gross Margin rose in five of the last eight quarters, with an average year-over-year change of +10.96 percentage points.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 132.66 percentage points in Q2 2023, against a drop of 145.80 percentage points in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 78.00% (Q1 2026), 84.98% (Q4 2025) and 69.49% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Novavax | 1.78 Bn | -1.23 Bn | 42.45 Mn | 74.87% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 74.87% |
| Mar 31, 2026 | 78.00% |
| Dec 31, 2025 | 84.98% |
| Sep 30, 2025 | 69.49% |
| Jun 30, 2025 | 93.59% |
| Mar 31, 2025 | 97.88% |
| Dec 31, 2024 | 58.48% |
| Sep 30, 2024 | 28.27% |
| Jun 30, 2024 | 88.87% |
| Mar 31, 2024 | 36.91% |
| Dec 31, 2023 | 46.81% |
| Sep 30, 2023 | 47.09% |
| Jun 30, 2023 | 86.86% |
| Mar 31, 2023 | 57.89% |
| Dec 31, 2022 | 49.14% |
| Sep 30, 2022 | 40.84% |
| Jun 30, 2022 | -45.80% |
| Mar 31, 2022 | 97.84% |
| Dec 31, 2021 | 100.00% |
| Sep 30, 2021 | 100.00% |
API Access
Novavax Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();